Trial Profile
Study of change of bone mass density (BMD) by prior drug and measurement site after one- year administration of denosumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 23 May 2018 New trial record